[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578812":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":20,"locations":29,"responsibleParty":47,"collaborators":7,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":7,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":32,"whyStopped":7,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"General University Hospital, Prague","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"PROCEDURE","tru-cut biopsy","needle biopsy from the tumor",[14],"core-cut biopsy",[16],{"name":17,"affiliation":18,"role":19},"David Cibula, prof.","Department of Gynecology, Obstetrics and Neonatology","STUDY_CHAIR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},"Renata Poncová, MD.","CONTACT","+420731573737","poncova.renata@gmail.com",{"name":27,"role":23,"phone":7,"phoneExt":7,"email":28},"Filip Frühauf, MD.","filip.fruehauf@vfn.cz",[30],{"facility":31,"status":32,"city":33,"state":7,"zip":34,"country":35,"countryCode":7,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Department of Gynecology, Obstetrics and Neonatology of First Faculty of Medicine and General University Hospital in Prague","RECRUITING","Prague","12800","Czechia",{"type":37,"coordinates":38},"Point",[39,40],14.42076,50.08804,{"lat":40,"lon":39},[43,45],{"name":44,"role":23,"phone":24,"phoneExt":7,"email":25},"Renata Poncová",{"name":46,"role":23,"phone":7,"phoneExt":7,"email":28},"Filip Frühauf",{"type":48,"investigatorFullName":44,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Principal Investigator","100578812","tru-cut-biopsy-in-tumor-characterisation-100578812",false,"NCT06816160","TRU-Cut Biopsy in Tumor cHaracterisation","Tru-cut Biopsy in Tumor Characterisation","TRUTH","Inclusion Criteria: Presence of a pelvic\u002Fabdominal lesion with suspicion of malignancy:\n\n1. new diagnosis of a presumed gynecologic tumor\n2. suspicious recurrence or progression of a known gynecologic malignancy\n3. pelvic\u002Fabdominal spread or recurrence of a non-gynecologic tumor (primary tumor or metastasis)\n4. pelvic\u002Fabdominal spread of a tumor of unknown origin 2. Age ≥18 years 3. Eastern Cooperative Oncology Group (ECOG) performance status grade \\\u003C3 4. Not pregnant 5. Signed informed consent form\n\nExclusion Criteria:\n\n1. Considered by the investigator to be unsuitable for any treatment\n2. Early stage disease\n3. Age \\\u003C18 years","FEMALE","18 Years",{"count":61,"type":62},250,"ESTIMATED","OBSERVATIONAL","Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.",[66],"Tumor",[68,69,70,71,72,73],"tumor","biopsy","tru-cut","core-cut","cancer","pelvic tumor","2025-02-05",{"date":76,"type":77},"2025-02-10","ACTUAL",{"date":79,"type":77},"2024-02-01",{"date":81,"type":62},"2027-01-31",{"name":5,"class":6},1]